BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31126000)

  • 1. The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen.
    Swystun LL; Ogiwara K; Lai JD; Ojala JRM; Rawley O; Lassalle F; Notley C; Rengby O; Michels A; Nesbitt K; Tryggvason K; Lillicrap D
    J Thromb Haemost; 2019 Aug; 17(8):1384-1396. PubMed ID: 31126000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent manner.
    Swystun LL; Notley C; Georgescu I; Lai JD; Nesbitt K; James PD; Lillicrap D
    J Thromb Haemost; 2019 Apr; 17(4):681-694. PubMed ID: 30740857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis.
    Swystun LL; Michels A; Lillicrap D
    J Thromb Haemost; 2023 Aug; 21(8):2007-2019. PubMed ID: 37085036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity.
    Swystun LL; Lai JD; Notley C; Georgescu I; Paine AS; Mewburn J; Nesbitt K; Schledzewski K; Géraud C; Kzhyshkowska J; Goerdt S; Hopman W; Montgomery RR; James PD; Lillicrap D
    J Clin Invest; 2018 Aug; 128(9):4057-4073. PubMed ID: 30124466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
    Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
    J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII pharmacokinetics associates with genetic modifiers of VWF and FVIII clearance in an adult hemophilia A population.
    Ogiwara K; Swystun LL; Paine AS; Kepa S; Choi SJ; Rejtö J; Hopman W; Pabinger I; Lillicrap D
    J Thromb Haemost; 2021 Mar; 19(3):654-663. PubMed ID: 33219619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5.
    Pegon JN; Kurdi M; Casari C; Odouard S; Denis CV; Christophe OD; Lenting PJ
    Haematologica; 2012 Dec; 97(12):1855-63. PubMed ID: 22733016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms.
    Sacco M; Lancellotti S; Branchini A; Tardugno M; Testa MF; Lunghi B; Bernardi F; Pinotti M; Giusti B; Castaman G; De Cristofaro R
    J Thromb Haemost; 2022 Aug; 20(8):1818-1829. PubMed ID: 35596664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo.
    van Schooten CJ; Shahbazi S; Groot E; Oortwijn BD; van den Berg HM; Denis CV; Lenting PJ
    Blood; 2008 Sep; 112(5):1704-12. PubMed ID: 18559674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shear stress is required for the endocytic uptake of the factor VIII-von Willebrand factor complex by macrophages.
    Castro-Núñez L; Dienava-Verdoold I; Herczenik E; Mertens K; Meijer AB
    J Thromb Haemost; 2012 Sep; 10(9):1929-37. PubMed ID: 22812646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A.
    Delignat S; Repessé Y; Navarrete AM; Meslier Y; Gupta N; Christophe OD; Kaveri SV; Lacroix-Desmazes S
    Haemophilia; 2012 Mar; 18(2):248-54. PubMed ID: 22044692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.
    Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J
    Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-affinity von Willebrand factor binding does not affect the anatomical or hepatocellular distribution of factor VIII in rats.
    Øie CI; Roepstorff K; Behrens C; Bøggild Kristensen J; Karpf DM; Bolt G; Gudme CN; Kjalke M; Smedsrød B; Appa RS
    J Thromb Haemost; 2016 Sep; 14(9):1803-13. PubMed ID: 27378673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor.
    Kroner PA; Foster PA; Fahs SA; Montgomery RR
    Blood; 1996 Feb; 87(3):1013-21. PubMed ID: 8562925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels.
    Antoni G; Oudot-Mellakh T; Dimitromanolakis A; Germain M; Cohen W; Wells P; Lathrop M; Gagnon F; Morange PE; Tregouet DA
    BMC Med Genet; 2011 Aug; 12():102. PubMed ID: 21810271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor.
    Elsheikh E; Lavin M; Heck LA; Larkin N; Mullaney B; Doherty D; Kennedy M; Keenan C; Guest T; O'Mahony B; Fazavana J; Fallon PG; Preston RJS; Gormley J; Ryan K; O'Connell NM; Singleton E; Byrne M; McGowan M; Roche S; Doyle M; Crowley MP; O'Shea SI; Reipert BM; Johnsen JM; Pipe SW; Di Paola J; Turecek PL; O'Donnell JS;
    J Thromb Haemost; 2023 May; 21(5):1123-1134. PubMed ID: 36775768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.
    Schwarz HP; Schlokat U; Mitterer A; Váradi K; Gritsch H; Muchitsch EM; Auer W; Pichler L; Dorner F; Turecek PL
    Semin Thromb Hemost; 2002 Apr; 28(2):215-26. PubMed ID: 11992244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice.
    Schwarz HP; Lenting PJ; Binder B; Mihaly J; Denis C; Dorner F; Turecek PL
    Blood; 2000 Mar; 95(5):1703-8. PubMed ID: 10688827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Storage of factor VIII variants with impaired von Willebrand factor binding in Weibel-Palade bodies in endothelial cells.
    van den Biggelaar M; Bouwens EA; Voorberg J; Mertens K
    PLoS One; 2011; 6(8):e24163. PubMed ID: 21909383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.